How to Get Pomalyst (pomalidomide) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide
Answer Box: Getting Pomalyst Covered by Blue Cross Blue Shield in New Jersey
Pomalyst (pomalidomide) requires prior authorization from Blue Cross Blue Shield plans in New Jersey for multiple myeloma treatment. To get approved: (1) Ensure your oncologist documents prior lenalidomide and proteasome inhibitor failures with progression within 60 days,